The pharmaceutical industry is pleased with the draft European Medicines Agencies Network strategy for the 2020–2025 period. However, in a press release issued on 8 September, the network suggests a series of improvements, such as redesigning the product support mechanism, which should be more iterative and flexible.
The draft strategy was published on the European Medicines Agency (EMA) website in early July. It is intended to serve as a guide for the European Medicines Agencies...